# Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

> **NCT02464332** · PHASE1 · WITHDRAWN · sponsor: **Blaze Bioscience Inc.**

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** BLZ-100

## Key facts

- **NCT ID:** NCT02464332
- **Lead sponsor:** Blaze Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study did not enroll any subjects
- **Last updated:** 2016-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464332, "Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02464332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*